Influenza A (H1N1) neuraminidase inhibitors from Vitis amurensis

被引:44
作者
Nguyen, Thi Ngoc Anh [1 ]
Dao, Trong Tuan [1 ]
Tung, Bui Thanh [1 ]
Choi, Hwanwon [2 ]
Kim, Eunhee [2 ]
Park, Junsoo [3 ]
Lim, Seong-Il [4 ]
Oh, Won Keun [1 ]
机构
[1] Chosun Univ, Coll Pharm, Project Team BK21, Kwangju 501759, South Korea
[2] Choong Ang Vaccine Lab, Taejon 305348, South Korea
[3] Yonsei Univ, Div Biol Sci & Technol, Wonju 220100, South Korea
[4] Korea Food Res Inst, Tradit Food Res Grp, Songnam 463746, South Korea
关键词
Influenza A; Neuraminidase inhibitors; Oseltamivir resistance; Vitis amurensis; Oligostilbenes; COMBINATION THERAPY; VIRUS INFECTION; VINIFERA KYOHOU; OLIGOSTILBENES; MICE; RESVERATROL; RIMANTADINE; COIGNETIAE; ROOTS; CELLS;
D O I
10.1016/j.foodchem.2010.06.049
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Recently, a novel H1N1 influenza A virus (H1N1/09 virus) was identified and considered a strong candidate for a novel influenza pandemic. As part of an ongoing anti-influenza screening programme on natural products, eight oligostilbenes were isolated as active principles from the methanol extract of Vitis amurensis. This manuscript reports the isolation, structural elucidation, and anti-viral activities of eight compounds on various neuraminidases from influenza A/PR/8/34 (H1N1), novel swine-origin influenza A (H1N1), and oseltamivir-resistant novel H1N1 (H274Y) expressed in 293T cells. The inhibition model of compounds 4, 6, and 7 which showed the strongest activity on the neuraminidases was examined. Detailed kinetic analysis indicated that they were all non-competitive. The synergistic effect of a combination of these non-competitive inhibitors with oseltamivir makes them a potential possibility for the control of influenza infections. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:437 / 443
页数:7
相关论文
共 28 条
  • [1] Alymova I. V., 2005, Current Drug Targets - Infectious Disorders, V5, P401, DOI 10.2174/156800505774912884
  • [3] Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team
    Dawood, Fatimah S.
    Jain, Seema
    Finelli, Lyn
    Shaw, Michael W.
    Lindstrom, Stephen
    Garten, Rebecca J.
    Gubareva, Larisa V.
    Xu, Xiyan
    Bridges, Carolyn B.
    Uyeki, Timothy M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (25) : 2605 - 2615
  • [4] Galabov Angel S., 2006, Antiviral Chemistry & Chemotherapy, V17, P251
  • [5] NEURAMINIDASE - THE SPECIFIC ENZYME OF INFLUENZA VIRUS AND VIBRIO-CHOLERAE
    GOTTSCHALK, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1957, 23 (03) : 645 - 646
  • [6] Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells
    Govorkova, EA
    Fang, HB
    Tan, M
    Webster, RG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4855 - 4863
  • [7] Stilbenes and oligostilbenes from leaf and stem of Vitis amurensis and their cytotoxic activity
    Ha, Do Thi
    Chen, Quan Cheng
    Hung, Tran Manh
    Youn, Ui Joung
    Ngoc, Tran Minh
    Thuong, Phuong Thien
    Kim, Hong Jin
    Seong, Yeon Hee
    Min, Byung Sun
    Bae, KiHwan
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2009, 32 (02) : 177 - 183
  • [8] Anti-inflammatory tetramers of resveratrol from the roots of Vitis amurensis and the conformations of the seven-membered ring in some oligostilbenes
    Huang, KS
    Lin, M
    Cheng, GF
    [J]. PHYTOCHEMISTRY, 2001, 58 (02) : 357 - 362
  • [9] Oligostilbenes from the roots of Vitis amurensis
    Huang, KS
    Lin, M
    [J]. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 1999, 2 (01) : 21 - 28
  • [10] Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses
    Hurt, Aeron C.
    Holien, Jessica K.
    Parker, Michael W.
    Barr, Ian G.
    [J]. DRUGS, 2009, 69 (18) : 2523 - 2531